Peripheral blood CD31+ cells for the treatment of ischemic vascular disease
- PMID: 20688216
- DOI: 10.1016/j.jacc.2010.01.069
Peripheral blood CD31+ cells for the treatment of ischemic vascular disease
Comment on
-
Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease.J Am Coll Cardiol. 2010 Aug 10;56(7):593-607. doi: 10.1016/j.jacc.2010.01.070. J Am Coll Cardiol. 2010. PMID: 20688215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical